These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Efficacy Profile of Ivabradine in Patients with Heart Failure plus Angina Pectoris. Borer JS; Swedberg K; Komajda M; Ford I; Tavazzi L; Böhm M; Depre C; Wu Y; Maya J; Dominjon F Cardiology; 2017; 136(2):138-144. PubMed ID: 27614723 [TBL] [Abstract][Full Text] [Related]
29. Innovation in coronary artery disease and heart failure: clinical benefits of pure heart rate reduction with ivabradine. Canet E; Lerebours G; Vilaine JP Ann N Y Acad Sci; 2011 Mar; 1222():90-9. PubMed ID: 21434947 [TBL] [Abstract][Full Text] [Related]
31. Selective and specific inhibition of If with ivabradine for the treatment of coronary artery disease or heart failure. Deedwania P Drugs; 2013 Sep; 73(14):1569-86. PubMed ID: 24065301 [TBL] [Abstract][Full Text] [Related]
33. The effects of heart rate control in chronic heart failure with reduced ejection fraction. Grande D; Iacoviello M; Aspromonte N Heart Fail Rev; 2018 Jul; 23(4):527-535. PubMed ID: 29687317 [TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of ivabradine in patients with chronic systolic heart failure and diabetes: an analysis from the SHIFT trial. Komajda M; Tavazzi L; Francq BG; Böhm M; Borer JS; Ford I; Swedberg K; Eur J Heart Fail; 2015 Dec; 17(12):1294-301. PubMed ID: 26377342 [TBL] [Abstract][Full Text] [Related]
35. Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial. Komajda M; Isnard R; Cohen-Solal A; Metra M; Pieske B; Ponikowski P; Voors AA; Dominjon F; Henon-Goburdhun C; Pannaux M; Böhm M; Eur J Heart Fail; 2017 Nov; 19(11):1495-1503. PubMed ID: 28462519 [TBL] [Abstract][Full Text] [Related]
36. Impact of Ivabradine on Health-Related Quality of Life of Patients with Ischaemic Chronic Heart Failure. Sallam M; Al-Saadi T; Alshekaili L; Al-Zakwani I Curr Vasc Pharmacol; 2016; 14(5):481-486. PubMed ID: 27145825 [TBL] [Abstract][Full Text] [Related]
37. Effect of ivabradine in heart failure: a meta-analysis of heart failure patients with reduced versus preserved ejection fraction. Tóth N; Soós A; Váradi A; Hegyi P; Tinusz B; Vágvölgyi A; Orosz A; Solymár M; Polyák A; Varró A; Farkas AS; Nagy N Can J Physiol Pharmacol; 2021 Nov; 99(11):1159-1174. PubMed ID: 34636643 [TBL] [Abstract][Full Text] [Related]
38. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Böhm M; Swedberg K; Komajda M; Borer JS; Ford I; Dubost-Brama A; Lerebours G; Tavazzi L; Lancet; 2010 Sep; 376(9744):886-94. PubMed ID: 20801495 [TBL] [Abstract][Full Text] [Related]